Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, May 31, 2016

Recent progress in tracking the viability of transplanted stem cells in vivo

If the stem cell company or researchers you are following don't mention tracking of stem cells then they have NO fucking clue if they survive or not. You can attribute that to laziness or fraud, but regardless not doing so is incompetent.
http://phys.org/news/2016-05-tracking-viability-transplanted-stem-cells.html
Noninvasive cell-tracking methods are indispensable for assessing the safety and efficacy of stem-cell based therapy. Thus, the research of noninvasive cell-tracking methods for determining in vivo the translocation and long-term viability of the transplanted stem cells have received considerable attention. A recent review article summarized the recent progress in tracking the viability of the transplanted stem cells in vivo.

In the article coauthored with S. Lin, G. Chen, D. Huang, C. Meng, and Q. Wang, scholars at Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, and College of Biological Science and Technology, Fuzhou University summarized the current methods for tracking the viability of the transplanted stem cells in vivo, including reporter-gene based methods, exogenous contrast label-based methods and multimodel imaging methods.

In recent decades, stem cell-based regenerative medicine has attracted intense attention and extraordinary expectation due to its potentials in the treatment of numerous major diseases, such as hepatic, cardiac, pulmonary, renal and neurological diseases.

Knowing the viability, distribution and differentiation of the transplanted stem cells in vivo is a prerequisite for better understanding the role of stem cells playing in the therapeutic process, in which the survival report of the transplanted stem cells in vivo is particularly crucial in determining the success of stem cell-based regenerative medicine. Therefore, the development of non-invasive imaging methods that can monitor the viability of the transplanted stem cells in situ is urgently needed.

In this article, the authors summarized the development history of stem cell-tracking imaging techniques, explained the imaging principles, pros and cons underlying these techniques, and provided an overview of the applications of these techniques in animal models or humans. Furthermore, this review provided a guideline for researchers to select the right tracking method for the right study. Finally, this review discussed the current challenges in tracking the viability of transplanted stem cells, and emphasized the promise of the combined NIR-II fluorescence imaging/BLI method and MRI/PET method for further applications in high-throughput cell therapy screening in animal models and safe imaging in clinical trials, respectively.

Explore further: Researchers track neural stem cells by coloring chicken eggs from the inside

More information: SuYing LIN et al. Progress of tracking the viability of transplanted stem cells, Chinese Science Bulletin (Chinese Version) (2016). DOI: 10.1360/N972015-01404


Image at link.



Noninvasive cell-tracking methods are indispensable for assessing the safety and efficacy of stem-cell based therapy. Thus, the research of noninvasive cell-tracking methods for determining in vivo the translocation and long-term viability of the transplanted stem cells have received considerable attention. A recent review article summarized the recent progress in tracking the viability of the transplanted stem cells in vivo.
In the article coauthored with S. Lin, G. Chen, D. Huang, C. Meng, and Q. Wang, scholars at Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, and College of Biological Science and Technology, Fuzhou University summarized the current methods for tracking the of the in vivo, including reporter-gene based methods, exogenous contrast label-based methods and multimodel imaging methods.
In recent decades, stem cell-based regenerative medicine has attracted intense attention and extraordinary expectation due to its potentials in the treatment of numerous major diseases, such as hepatic, cardiac, pulmonary, renal and neurological diseases.
Knowing the viability, distribution and differentiation of the transplanted stem cells in vivo is a prerequisite for better understanding the role of stem cells playing in the therapeutic process, in which the survival report of the transplanted stem cells in vivo is particularly crucial in determining the success of stem cell-based regenerative medicine. Therefore, the development of non-invasive imaging methods that can monitor the viability of the transplanted stem cells in situ is urgently needed.
In this article, the authors summarized the development history of stem cell-tracking imaging techniques, explained the imaging principles, pros and cons underlying these techniques, and provided an overview of the applications of these techniques in animal models or humans. Furthermore, this review provided a guideline for researchers to select the right tracking method for the right study. Finally, this review discussed the current challenges in tracking the viability of transplanted , and emphasized the promise of the combined NIR-II fluorescence imaging/BLI method and MRI/PET method for further applications in high-throughput cell therapy screening in animal models and safe imaging in clinical trials, respectively.
More information: SuYing LIN et al. Progress of tracking the viability of transplanted stem cells, Chinese Science Bulletin (Chinese Version) (2016). DOI: 10.1360/N972015-01404


Read more at: http://phys.org/news/2016-05-tracking-viability-transplanted-stem-cells.html#jCp

No comments:

Post a Comment